On January 24, 2011, the Mass Torts Unit of Searcy Denney filed yet another individual lawsuit in Palm Beach County, Florida on behalf of a client harmed by ingestion of Bayer’s beleaguered Yaz and Yasmin birth control pills. This latest civil claim was filed on behalf of a 39 year […]
Category: Defective Drugs
Searcy Denney filed a lawsuit on January 4, 2011 in the coordinated proceedings pending in Philadelphia against a number of drug companies who were involved in the manufacture and sale of the brand name drug Reglan as well as metoclopramide, its generic equivalent. This latest filing was on behalf of […]
The Mass Torts Unit of Searcy Denney filed an individual lawsuit on December 10, 2010 against the manufacturer of Avandia on behalf of a Jacksonville man, who suffered severe congestive heart failure and worsening of his heart disease after ingesting the insulin sensitizer. The case was filed in federal court […]
On December 29, 2011 the Judicial Panel on Multidistrict Litigation (JPML) entered an Order consolidating all pending federal Actos bladder cancer lawsuits. Actos, generically known as pioglitazone, is a prescription medication manufactured by Takeda Pharmaceuticals and used to treat Type 2 diabetes, often referred to as adult onset diabetes. The […]
Progressive Multifocal Leukoencephalopathy (PML) is a devastating diagnosis. It is similar to ALS and other progressive neurological diseases that slowly rob patients of their mobility and functioning. PML is caused by a virus that attacks the central nervous system. Once PML has developed, patients quickly experience a decline in their […]
A startling article entitled, “Conflict of Interest in the Assessment of Thromboprophylaxis” appeared in the January 2012 issue of The Journal of Bone & Joint Surgery. A group of investigators were curious about the possibility of bias during evidence-based reviews and they conducted a retrospective study, centering on prescription choice […]
Pradaxa (also known as Dabigatran Etexilate) is an inactive “parent” drug that relies on the body’s metabolism to eventually manufacture a form of the drug that the body can use as an anti-coagulant, a process that occurs after the drug has been ingested by a patient. Anti-coagulants such as Warfarin […]
In late 2010, the FDA approved the drug called Pradaxa (dabigatran); manufactured by Boehringer Ingelheim. Pradaxa is a blood thinner and is supposed to be prescribed to patients who suffer from the cardiac disorder atrial fibrillation. Atrial Fibrillation is the most common form of abnormal heart rhythm. Patients who suffer […]
Has it simply become all about bean counters and number crunching for some drug companies?
If you can generate over $1.5.8 billion in sales for (5) years, for a drug you know is defective, can you afford to pay the claims that result from people being hurt or killed?
In 2010, the U.S. Food & Drug Administration approved Pradaxa (Dabigatran Etexilate). Pradaxa acts as a blood “thinner” and is promoted to reduce the risk of stroke and blood clots in people with atrial fibrillation. Atrial fibrillation, affecting over two million Americans, occurs when the heart does not beat properly […]
